Abbott (NYSE: ABT) reported Q2 EPS of $1.08, $0.03 better than the analyst estimate of $1.05. Revenue for the quarter came in at $10 billion versus the consensus estimate of $9.69 billion.

GUIDANCE:

Abbott sees FY2023 EPS of $4.30-$4.50, versus the consensus of $4.40.

For earnings history and earnings-related data on Abbott (ABT) click here.